Dr. Yi Wang's lab focuses on developing innovative MRI techniques to improve the diagnosis and treatment of neurological conditions such as stroke and Alzheimer's disease. They use fluid mechanics principles to enhance tissue perfusion imaging and create new methods for mapping oxygen metabolism in the brain. By refining these MRI-based tools, the lab aims to provide more accurate and reliable assessments of brain health, ultimately aiding in patient management and clinical decision-making.

Dr. Chunyu Wang's lab at Rensselaer Polytechnic Institute focuses on understanding how variations in the ApoE gene influence the risk of developing Alzheimer's Disease. By exploring the interactions between ApoE and heparan sulfate, a molecule present in the brain, the lab aims to uncover how these binding mechanisms contribute to Alzheimer's pathogenesis. The research combines biochemistry, cell biology, and animal model studies to identify new targets for Alzheimer's treatments.

Dr. Xiaoqin Wang's lab at Johns Hopkins University focuses on developing tools for gene editing in marmosets, which are small primates that can serve as valuable models for studying human brain diseases. The lab works on refining genetic manipulation techniques to create genetically modified marmosets that can help us understand brain function and neurobiology. By establishing a colony of marmosets and employing advanced genetic technologies, the research aims to generate innovative models that could pave the way for new therapies for brain-related disorders.

Dr. Jing Wang's lab focuses on improving radiation therapy for patients with head and neck cancer by developing advanced predictive models to identify cancerous lymph nodes. They use machine learning techniques to analyze imaging data and patient information to enhance treatment efficacy while reducing side effects. The goal is to change how radiation is applied, making it more precise and minimizing harm to healthy tissues.

Dr. Jeffrey B Ware's lab focuses on understanding how traumatic brain injuries (TBIs) can lead to long-term cognitive decline and dementia, specifically through the lens of microvascular injury. By using advanced MRI techniques, the lab investigates how changes in brain blood flow and vascular health after TBIs contribute to brain degeneration over time. This research aims to improve patient outcomes by identifying new ways to predict and treat cognitive impairments resulting from TBIs.

Dr. Christine O'Brien's lab works on developing innovative wearable devices that can help monitor blood loss during childbirth, specifically aiming to address postpartum hemorrhage (PPH). By creating technologies that non-invasively measure important cardiovascular parameters, the lab seeks to provide early detection of PPH, which is crucial for improving patient outcomes and reducing maternal mortality. The research combines biomedical engineering and real-world clinical applications to enhance maternal health.

Dr. Ashley Weaver's lab at Wake Forest University focuses on understanding the relationship between muscle and bone health in older adults to help prevent osteoporotic fractures. By utilizing advanced imaging techniques and analyses, the lab aims to discover how muscle properties affect bone strength over time through a study of aging individuals. This research could lead to better methods for identifying those at risk of fractures and creating targeted interventions to improve overall musculoskeletal health.

Dr. James D. Weiland's lab focuses on developing advanced technologies to restore vision to individuals with retinal degeneration. They work on creating innovative retinal prosthetics that improve visual acuity and quality, as well as systems to assist visually impaired individuals with navigation using multimodal interfaces. Through a combination of engineering and neurobiology, the lab aims to enhance the functional capabilities of assistive devices in everyday life.

Dr. David Welch's lab focuses on using far-UVC irradiation as a safe method to reduce airborne disease transmission, particularly in healthcare settings. By examining the effects of these wavelengths on human health and safety, the research aims to create a new intervention technology that effectively inactivates airborne viruses without harming individuals present in the environment. Their work has significant implications for public health, especially in preventing outbreaks of diseases like COVID-19 and influenza.

Dr. David Kevin Wood's lab at the University of Minnesota focuses on developing new ways to measure and understand sickle cell disease (SCD) through biomarkers. They aim to find specific cells' properties that can predict clinical outcomes to improve patient care and treatment strategies. By combining biochemical and mechanical measurements of red blood cells, the lab is paving the way for more effective monitoring and therapy for SCD patients.

Dr. Pamela K Woodard's lab focuses on understanding carotid artery diseases, specifically atherosclerosis, which can lead to strokes. Using advanced PET imaging techniques, the research aims to differentiate between patients at high risk of plaque rupture and those who may not need surgical intervention. By studying specific molecular markers in patients, the lab hopes to improve treatment strategies and reduce unnecessary healthcare costs.

Dr. Guillermo Antonio Ameer's research focuses on improving wound healing for diabetic patients. His lab develops innovative medical devices, particularly a smart bandage that not only promotes healing but also monitors wound conditions in real time. This work aims to reduce complications like infections and amputations associated with diabetic foot ulcers.

Dr. Holden H. Wu's lab at UCLA focuses on improving the diagnosis and treatment of liver diseases and abdominal cancers using advanced MRI technology. The team develops new non-invasive imaging techniques that help doctors distinguish between different types of liver disease and enhance real-time guidance for minimally invasive surgical procedures. This innovative research aims to reduce the need for invasive biopsies and improve patient outcomes in cancer treatment.

Dr. Yun Wu's lab focuses on developing innovative methods for early lung cancer detection and monitoring patients' responses to immunotherapy treatments. By utilizing a non-invasive liquid biopsy approach called the Exo-PROS assay, the team aims to identify specific biomarkers from tumor-derived exosomes found in blood samples. This research seeks to improve the accuracy and effectiveness of lung cancer diagnostics, ultimately enhancing patient outcomes through better treatment strategies.

Dr. Jia Wu's lab focuses on improving treatments for early-stage non-small cell lung cancer (NSCLC) using immunotherapy. They are researching how imaging can help identify patients who will benefit most from neoadjuvant immunotherapy before surgery. By developing new imaging biomarkers, the lab aims to enhance the effectiveness of cancer treatments and provide personalized medicine strategies for lung cancer patients.

Dr. Xiaoping Wu's lab at the University of Minnesota focuses on advancing MRI technology to allow deeper insights into the human brain. By working with ultrahigh magnetic fields, the lab develops innovative tools to achieve much clearer images of brain function than current methods allow. This research could significantly impact our understanding of how the brain works, particularly in health and disease.

Dr. Yu-Chien Wu's lab at Indiana University Indianapolis focuses on understanding neurodegenerative diseases like Alzheimer's by using advanced MRI techniques. The lab explores how these imaging methods can detect changes in brain synapses associated with memory decline. By studying animal models and applying findings to human health, they aim to improve early diagnosis and treatment options for Alzheimer's disease.

Dr. Marcelo Victor Wust Zibetti's lab focuses on developing advanced imaging techniques to improve the early diagnosis of knee osteoarthritis, a common disability among older adults. The research emphasizes the use of magnetic resonance imaging (MRI) to assess cartilage health by analyzing structures non-invasively. This work aims to create faster and more accurate imaging methods to identify changes in cartilage before physical symptoms arise, ultimately contributing to better prevention strategies for knee osteoarthritis.

Dr. Shawn Xiang's research lab at the University of California, Irvine focuses on advancing proton therapy for cancer treatment through innovative imaging technologies. The lab is developing new methods to accurately map the Bragg peak—where proton therapy is most effective—using protoacoustic and ultrasound imaging. This research aims to improve treatment precision, enhance patient safety, and facilitate clinical adoption of new dosimetry techniques. By integrating these imaging systems, the lab seeks to push the boundaries of radiation oncology and reduce side effects of treatment for patients.

Dr. Xiang Xu's research lab focuses on understanding the neurological aspects of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), particularly in patients who have experienced long-term effects after COVID-19, known as Post-Acute Sequelae of SARS-CoV-2 infection (PASC). The lab utilizes advanced imaging techniques to investigate how brain metabolism and circulation differ between PASC patients and those with classic ME/CFS. This research aims to uncover potential shared mechanisms underlying these conditions, which may open up new avenues for diagnosis and treatment.